We are live on ! Find out more
VMD icon

Viemed Healthcare

141 hedge funds and large institutions have $202M invested in Viemed Healthcare in 2024 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 45 increasing their positions, 28 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more call options, than puts

Call options by funds: $18K | Put options by funds: $2K

275% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 8

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

61% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 28

17% more funds holding

Funds holding: 121141 (+20)

9% more capital invested

Capital invested by funds: $186M → $202M (+$16.2M)

0.33% less ownership

Funds ownership: 64.92%64.59% (-0.33%)

Holders
141
Holders Change
+20
Holders Change %
+16.53%
% of All Funds
1.86%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
30
Increased
45
Reduced
28
Closed
8
Calls
$18K
Puts
$2K
Net Calls
+$16K
Net Calls Change
-$24K
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
76
Deutsche Bank
Germany
$186K +$195K +22,438 +2,891%
OAM
77
Oppenheimer Asset Management
New York
$185K -$62.2K -7,167 -24%
William Blair & Company
78
William Blair & Company
Illinois
$184K
VCM
79
Violich Capital Management
California
$180K
BA
80
BCM Advisors
Louisiana
$177K
MIM
81
MetLife Investment Management
New Jersey
$160K
State of Tennessee, Department of Treasury
82
State of Tennessee, Department of Treasury
Tennessee
$160K
MPM
83
MBB Public Markets
Illinois
$159K
Mirae Asset Global ETFs Holdings
84
Mirae Asset Global ETFs Holdings
Hong Kong
$157K +$7.25K +836 +4%
UIA
85
Ulland Investment Advisors
Minnesota
$157K -$50.8K -5,850 -23%
CF
86
Corebridge Financial
Texas
$137K -$11.2K -1,287 -7%
JF
87
Jump Financial
Illinois
$136K +$147K +17,000 New
DWM
88
Dorchester Wealth Management
Quebec, Canada
$132K
Wells Fargo
89
Wells Fargo
California
$129K +$47.4K +5,461 +52%
IIM
90
INTECH Investment Management
Florida
$125K +$135K +15,595 New
Invesco
91
Invesco
Georgia
$123K +$2.56K +295 +2%
BP
92
BBR Partners
New York
$120K
SIP
93
Stoneridge Investment Partners
Pennsylvania
$113K +$22.2K +2,559 +22%
Two Sigma Advisers
94
Two Sigma Advisers
New York
$110K -$305K -35,100 -72%
HSBC Holdings
95
HSBC Holdings
United Kingdom
$108K +$116K +13,425 New
VOYA Investment Management
96
VOYA Investment Management
Georgia
$108K +$1.13K +130 +1%
T. Rowe Price Associates
97
T. Rowe Price Associates
Maryland
$105K +$17.3K +1,997 +18%
Manulife (Manufacturers Life Insurance)
98
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$104K -$10.2K -1,181 -8%
TWC
99
TD Waterhouse Canada
Ontario, Canada
$98.2K -$3.38K -389 -3%
OAM
100
Oxford Asset Management
United Kingdom
$97.6K +$106K +12,170 New

VMD Hedge Fund Activity: Q4 2024 in Review

141 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q4 2024, worth a combined $202M — up 8.7% from $186M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new VMD positions and 8 closed out — a net gain of 22 holders — while 45 added to existing stakes and 28 trimmed.

The largest buyer was Divisadero Street Capital Management, adding an estimated $2.57M. The largest seller was Wasatch Advisors, cutting an estimated $4.52M.

  • 141 institutional investors held Viemed Healthcare (VMD) as of Q4 2024, up from 121 in Q3 2024.
  • Funds reported $202M of Viemed Healthcare stock for Q4 2024, up 8.7% quarter-over-quarter.
  • 30 funds opened new Viemed Healthcare positions in Q4 2024 and 8 closed out, a net change of +22 holders.
  • The largest Viemed Healthcare buyer in Q4 2024 was Divisadero Street Capital Management, an estimated $2.57M added.
  • The largest Viemed Healthcare seller in Q4 2024 was Wasatch Advisors, an estimated $4.52M sold.

Based on aggregated 13F filings for Q4 2024.